Not checked for notices yet.
865 iosH2 exerts potent anti-tumor activity by blocking LILRB1/2 and KIR3DL1 receptor signaling
Anil Kumar, Michael Curran, Christoph Renner and 6 more
Journal for ImmunoTherapy of Cancer · 2021
doi:10.1136/jitc-2021-sitc2021.865
Cited by papers we hold 1
- Emerging phagocytosis checkpoints in cancer immunotherapy · 2023No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.